The DOI matches its Crossref record.
Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor.
Abstract
The coordinate increase in the hepatic production of the acute phase plasma proteins appears to be mediated by several cytokines produced by different cell types. One factor, hepatocyte-stimulating factor III (HSF-III), constitutively produced by human squamous carcinoma (COLO-16) cells, stimulates the synthesis of the same set of acute phase plasma proteins as the structurally distinct IL-6. The physicochemical properties of HSF-III coincide with those of the T cell-derived leukemia-inhibitory factor (LIF). Human rLIF, tested on hepatoma cells, indicated a liver-regulating activity identical to HSF-III. The LIF activity is specifically neutralized by HSF-III antibodies. COLO-16 cells contain an LIF mRNA which is characteristic for lectin-stimulated T cells, suggesting that HSF-III is an epidermal cell-derived form of LIF. This result provides additional evidence for the close relationship between acute phase regulation of the liver and control of proliferation and differentiation of hemopoietic cells by identical cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3
Niwa, H., Burdon, T., Chambers, I., & Smith, A. (1998) · Genes & Development · doi:10.1101/gad.12.13.2048 · Cited by 1,549
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Interleukin 6 and its receptor: ten years later
Hirano, T. (1998) · International Reviews of Immunology · doi:10.3109/08830189809042997 · Cited by 788
Castell, J. V., Gómez-lechón, M. J., David, M., Fabra, R., Trullenque, R., & Heinrich, P. C. (1990) · Hepatology · doi:10.1002/hep.1840120517 · Cited by 757
Cytokines and the hepatic acute phase response
Moshage, H. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199703)181:3<257::aid-path756>3.0.co;2-u · Cited by 718
Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130.
Gearing, D. P., Thut, C. J., VandeBos, T., Gimpel, S. D., Delaney, P. B., King, J., Price, V., Cosman, D., & Beckmann, M. P. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07833.x · Cited by 590
Wegenka, U. M., Buschmann, J., Lütticken, C., Heinrich, P. C., & Horn, F. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.276 · Cited by 552
Yamamori, T., Fukada, K., Aebersold, R., Korsching, S., Fann, M.-J., & Patterson, P. H. (1989) · Science · doi:10.1126/science.2512641 · Cited by 550
Bhatt, H., Brunet, L. J., & Stewart, C. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11408 · Cited by 514
Effects of cytokines on the liver
Andus, T., Bauer, J., & Gerok, W. (1991) · Hepatology · doi:10.1002/hep.1840130226 · Cited by 419
IL-6 and NF-IL6 in acute-phase response and viral infection
Akira, S., & Kishimoto†, T. (1992) · Immunological Reviews · doi:10.1111/j.1600-065x.1992.tb01407.x · Cited by 411
Rose, T. M., & Bruce, A. G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8641 · Cited by 371
Nichols, J., Evans, E. P., & Smith, A. G. (1990) · Development · doi:10.1242/dev.110.4.1341 · Cited by 328
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.
Gabay, C., Smith, M. F., Eidlen, D., & Arend, W. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119488 · Cited by 319
Hack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
Rathjen, P. D., Toth, S., Willis, A., Heath, J. K., & Smith, A. G. (1990) · Cell · doi:10.1016/0092-8674(90)90387-t · Cited by 270
Ohno, M., & Abe, T. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90327-c · Cited by 265
Leukemia-Inhibitory Factor—Neuroimmune Modulator of Endocrine Function*
Auernhammer, C. J., & Melmed, S. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0400 · Cited by 264
Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes
Alles, V., Bottazzi, B., Peri, G., Golay, J., Introna, M., & Mantovani, A. (1994) · Blood · doi:10.1182/blood.v84.10.3483.3483 · Cited by 261
Hermanns, H. M., Radtke, S., Haan, C., Schmitz-Van de Leur, H., Tavernier, J., Heinrich, P. C., & Behrmann, I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6651 · Cited by 71
A new hepatocyte stimulating factor: cardiotrophin‐1 (CT‐1)
Peters, M., Roeb, E., Pennica, D., zum Büschenfelde, K.-H. M., & Rose-John, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00972-c · Cited by 39
Metadata
- Authors
- Baumann, H., & Wong, G. G.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1989-08
- Volume
- 143
- Issue
- 4
- Pages
- 1163-1167
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1482979909
- Cited by
- 269
- References
- 0
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.